PolyPid Announces Presentation of Clinical Data at Surgical Infection Society 2022 Annual Meeting

Presentation evaluates the addition of D-PLEX₁₀₀ to the surgical site infection standard of care prophylaxis regimen in elective colorectal surgery PETACH TIKVA, Israel , April 12, 2022 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD ) (“PolyPid” or the “Company”), a late-stage biopharma company